Apimeds Pharma US Ltd (APUS)
Apimeds Pharma US Ltd (APUS) is a common stock listing on the New York Stock Exchange. According to the available company description, the business is focused on digital asset treasury solutions related to bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, in the United Arab Emirates, and it operates as a subsidiary of Inscobee., Inc. The listing is classified as common equity and represents the equity interest in the issuer rather than a fund, preferred security, or debt instrument.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
NYSE-APUS
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
2.671 M
|
